Conference
The RADICAL-PC trial.
Abstract
178
Background: Cardiovascular disease (CVD) occurs frequently in men with prostate cancer (PC), but the reasons are unclear. Specifically, the role of androgen deprivation therapy (ADT) in promoting CVD remains uncertain. There is a lack of evidence to inform preventive strategies against CVD in this high risk group. It is unknown if the evidence to support CVD preventive strategies in the general population can be validly …
Authors
Pinthus JH; Klotz L; Lukka H; Duivenvoorden WC; Pettit S; Pohl K; Siemens DR; Fradet V; Mourtzakis M; Kavsac P
Volume
34
Pagination
pp. 178-178
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
January 10, 2016
DOI
10.1200/jco.2016.34.2_suppl.178
Conference proceedings
Journal of Clinical Oncology
Issue
2_suppl
ISSN
0732-183X